Interleukin 3D structures
From Proteopedia
(Difference between revisions)
| Line 21: | Line 21: | ||
**[[3o4o]] - hIL-1 β + IL-1 receptor 2 + IL-1 receptor accessory protein<BR /> | **[[3o4o]] - hIL-1 β + IL-1 receptor 2 + IL-1 receptor accessory protein<BR /> | ||
**[[4dep]] - hIL-1 β + IL-1 receptor 1 + IL-1 receptor accessory protein<BR /> | **[[4dep]] - hIL-1 β + IL-1 receptor 1 + IL-1 receptor accessory protein<BR /> | ||
| - | **[[4g6j]], [[4g6m]], [[5bvp]], [[7chy]], [[7chz]] - hIL-1 β + antibody<br /> | + | **[[4g6j]], [[4g6m]], [[5bvp]], [[7chy]], [[7chz]], 7z4t]] - hIL-1 β + antibody<br /> |
**[[2kh2]] - hIL-1 β + SCFV - NMR<BR /> | **[[2kh2]] - hIL-1 β + SCFV - NMR<BR /> | ||
**[[1md6]] – mIL-1F5 – mouse<BR /> | **[[1md6]] – mIL-1F5 – mouse<BR /> | ||
| Line 31: | Line 31: | ||
**[[1m47]], [[1m4c]], [[3ink]] – hIL-2<BR /> | **[[1m47]], [[1m4c]], [[3ink]] – hIL-2<BR /> | ||
| - | **[[3qb1]], [[7m2g]] - hIL-2 (mutant)<br /> | + | **[[3qb1]], [[7m2g]], [[7ra9]], [[7raa]] - hIL-2 (mutant)<br /> |
**[[1irl]] – hIL-2 (mutant) - NMR<BR /> | **[[1irl]] – hIL-2 (mutant) - NMR<BR /> | ||
**[[5m5e]] - hIL-2 + IL-2 receptor β + cytokine receptor common γ<BR /> | **[[5m5e]] - hIL-2 + IL-2 receptor β + cytokine receptor common γ<BR /> | ||
| Line 41: | Line 41: | ||
**[[4nej]], [[4nem]] – hIL-2 + methylfuran carboxylate derivative<BR /> | **[[4nej]], [[4nem]] – hIL-2 + methylfuran carboxylate derivative<BR /> | ||
**[[5lqb]], [[6ye3]], [[7dr4]] - hIL-2 + antibody<br /> | **[[5lqb]], [[6ye3]], [[7dr4]] - hIL-2 + antibody<br /> | ||
| + | **[[7zmz]] - hIL-2 + CD25<br /> | ||
**[[4yue]] - mIL-2 + antibody<br /> | **[[4yue]] - mIL-2 + antibody<br /> | ||
**[[4yqx]] - IL-2 + antibody - rat<br /> | **[[4yqx]] - IL-2 + antibody - rat<br /> | ||
**[[4zf7]] – hIL-2 - ferret<BR /> | **[[4zf7]] – hIL-2 - ferret<BR /> | ||
| + | **[[7cjn]], [[7d9m]] – IL-2 – grass carp<BR /> | ||
*IL-3 | *IL-3 | ||
| Line 77: | Line 79: | ||
**[[1il6]], [[2il6]] – hIL-6 - NMR<BR /> | **[[1il6]], [[2il6]] – hIL-6 - NMR<BR /> | ||
**[[1p9m]] - hIL-6 + IL-6 receptor α and β<br /> | **[[1p9m]] - hIL-6 + IL-6 receptor α and β<br /> | ||
| + | **[[8d82]] - hIL-6 + IL-6 receptor α and β – Cryo EM<br /> | ||
**[[5fuc]] - hIL-6 + IL-6 receptor α + VHH6<br /> | **[[5fuc]] - hIL-6 + IL-6 receptor α + VHH6<br /> | ||
**[[4j4l]] – hIL-6 + internalin B<BR /> | **[[4j4l]] – hIL-6 + internalin B<BR /> | ||
| Line 100: | Line 103: | ||
**[[6wzm]] – hIL-8 + antibody<BR /> | **[[6wzm]] – hIL-8 + antibody<BR /> | ||
**[[6lfm]], [[6lfo]]– hIL-8 in G-protein coupled receptor – Cryo EM<br /> | **[[6lfm]], [[6lfo]]– hIL-8 in G-protein coupled receptor – Cryo EM<br /> | ||
| + | |||
| + | *IL-9 | ||
| + | |||
| + | **[[7ox6]] – hIL-9 - NMR<BR /> | ||
| + | **[[7ox5]] - hIL-9 + IL—9 receptor a<br /> | ||
| + | **[[7ox1]], [[7ox2]], [[7ox3]] - hIL-9 + antibody<br /> | ||
| + | **[[7xcb]] – mIL-9 <BR /> | ||
| + | **[[7ox4]] – mIL-9 + antibody<BR /> | ||
*IL-10 | *IL-10 | ||
| Line 132: | Line 143: | ||
**[[3qwr]] - hIL-12 β + hIL- 23 α + adnectin<br /> | **[[3qwr]] - hIL-12 β + hIL- 23 α + adnectin<br /> | ||
**[[6uib]] - hIL-12 β + hIL- 23 α + peptide<br /> | **[[6uib]] - hIL-12 β + hIL- 23 α + peptide<br /> | ||
| - | **[[6sff]], [[6smc]], [[6sp3]] - mIL-12 β <br /> | + | **[[6sff]], [[6smc]], [[6sp3]], [[7pur]], [[7r3n]] - mIL-12 β <br /> |
*IL-13 | *IL-13 | ||
| Line 141: | Line 152: | ||
**[[3lb6]] - hIL-13 + IL-13 receptor α2<BR /> | **[[3lb6]] - hIL-13 + IL-13 receptor α2<BR /> | ||
**[[3bpo]], [[5e4e]] - hIL-13 residues 20-145 + IL-4 receptor α + IL-13 receptor α<br /> | **[[3bpo]], [[5e4e]] - hIL-13 residues 20-145 + IL-4 receptor α + IL-13 receptor α<br /> | ||
| - | **[[5l6y]] - hIL-13 + antibody<br /> | + | **[[5l6y]], [[7rew]] - hIL-13 + antibody<br /> |
*IL-15 | *IL-15 | ||
| Line 158: | Line 169: | ||
**[[4hr9]] - hIL-17A (mutant)<br /> | **[[4hr9]] - hIL-17A (mutant)<br /> | ||
**[[5n92]] - hIL-17A + hIL-17F <br /> | **[[5n92]] - hIL-17A + hIL-17F <br /> | ||
| + | **[[7uwm]] - hIL-17A + IL-17A receptor α – Cryo EM<br /> | ||
**[[4hsa]] - hIL-17A (mutant) + IL-17A receptor α <br /> | **[[4hsa]] - hIL-17A (mutant) + IL-17A receptor α <br /> | ||
**[[5nan]] - hIL-17A + hIL-17F + IL-17A receptor α <br /> | **[[5nan]] - hIL-17A + hIL-17F + IL-17A receptor α <br /> | ||
| - | **[[2vxs]], [[4qhu]], [[6wio]], [[6wir]] - hIL-17A + antibody<BR /> | + | **[[7uwn]] - hIL-17A + IL-17A receptor α + IL-17A receptor gamma<br /> |
| + | **[[7zan]] - hIL-17A (mutant) + IL-17A receptor α + IL-17A receptor gamma<br /> | ||
| + | **[[2vxs]], [[4qhu]], [[6wio]], [[6wir]], [[7wkx]], [[7z2m]] - hIL-17A + antibody<BR /> | ||
| + | **[[8b7w]], [[8dy1]], [[8dy5]] - hIL-17A + scFv<BR /> | ||
| + | **[[8dyf]], [[8dyg]], [[8dyh]], [[8dyi]] - hIL-17A + inhibitor<BR /> | ||
**[[5vb9]] - hIL-17A + peptide inhibitor<BR /> | **[[5vb9]] - hIL-17A + peptide inhibitor<BR /> | ||
| + | **[[7ama]], [[7amg]] - hIL-17A + modulator<br /> | ||
**[[5hi5]], [[5hi4]], [[5hi3]], [[5hhx]], [[5hhv]] - hIL-17A + peptide inhibitor + antibody<BR /> | **[[5hi5]], [[5hi4]], [[5hi3]], [[5hhx]], [[5hhv]] - hIL-17A + peptide inhibitor + antibody<BR /> | ||
**[[1jpy]], [[6hgo]] – hIL-17F<BR /> | **[[1jpy]], [[6hgo]] – hIL-17F<BR /> | ||
| Line 212: | Line 229: | ||
**[[6gg1]] - hIL-24<br /> | **[[6gg1]] - hIL-24<br /> | ||
**[[6df3]] - hIL-24 + IL—22 receptor α1 + IL-20 receptor β<br /> | **[[6df3]] - hIL-24 + IL—22 receptor α1 + IL-20 receptor β<br /> | ||
| + | |||
| + | *IL-25 | ||
| + | |||
| + | **[[7uwj]], [[7uwk]] - hIL-25 + IL—17 receptor b – Cryo EM<br /> | ||
| + | **[[7uwl]] - hIL-25 + IL—17 receptor a + IL—17 receptor b – Cryo EM<br /> | ||
| + | |||
| + | *IL-27 | ||
| + | |||
| + | **[[7u7n]], [[8d85]] - hIL-27 + IL—27 receptor a + IL-6 receptor b – Cryo EM<br /> | ||
| + | **[[7zxk]] - hIL-27 + antibody<br /> | ||
| + | **[[7zg0]] - mIL-27 + IL—27 receptor a <br /> | ||
| + | **[[7z0l]] - mIL-27 + IL—27 receptor a + IL-6 receptor b – Cryo EM<br /> | ||
*IL-28 | *IL-28 | ||
Current revision
3D structures of interleukin
Updated on 04-June-2023
